17:17 EST Aclaris Therapeutics (ACRS) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on ACRS: Aclaris Therapeutics reports Q4 EPS ($1.01), consensus (38c) Is ACRS a Buy, Before Earnings? Aclaris Therapeutics announces publication describing properties of ATI-2138 Aclaris Therapeutics Highlights Drug Progress and Financial Strength
